𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II trial of continuous low-dose oral cyclophosphamide and celecoxib in patients with renal cell carcinoma

✍ Scribed by Monika K. Krzyzanowska; Ian F. Tannock; Gina Lockwood; Jennifer Knox; Malcolm Moore; Georg A. Bjarnason

Publisher
Springer
Year
2006
Tongue
English
Weight
292 KB
Volume
60
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of Didemnin B in patients
Phase II trial of Didemnin B in patients with advanced renal cell carcinoma
✍ Robert Motzer; Howard Scher; Dean Bajorin; Cora Sternberg; George J. Bosl πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 115 KB

Twenty-three patients with advanced renal cell cancer were treated with Didemnin B. One partial response was achieved (5070) in 21 evaluable patients. An allergic reaction was noted in four patients including one patient with anaphylaxis. Didemnin B is not recommended in the treatment of renal cell